Does MITOMYCIN Cause Pulmonary veno-occlusive disease? 43 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 43 reports of Pulmonary veno-occlusive disease have been filed in association with MITOMYCIN (MUTAMYCIN). This represents 2.0% of all adverse event reports for MITOMYCIN.
43
Reports of Pulmonary veno-occlusive disease with MITOMYCIN
2.0%
of all MITOMYCIN reports
6
Deaths
23
Hospitalizations
How Dangerous Is Pulmonary veno-occlusive disease From MITOMYCIN?
Of the 43 reports, 6 (14.0%) resulted in death, 23 (53.5%) required hospitalization, and 6 (14.0%) were considered life-threatening.
Is Pulmonary veno-occlusive disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MITOMYCIN. However, 43 reports have been filed with the FAERS database.
What Other Side Effects Does MITOMYCIN Cause?
Off label use (292)
Drug ineffective (117)
Diarrhoea (116)
Nausea (100)
Neutropenia (96)
Thrombocytopenia (94)
Fatigue (88)
Disease progression (86)
Rash (67)
Vomiting (66)
What Other Drugs Cause Pulmonary veno-occlusive disease?
TREPROSTINIL (98)
MACITENTAN (90)
EPOPROSTENOL (67)
SELEXIPAG (66)
SILDENAFIL (57)
AMBRISENTAN (54)
CYCLOPHOSPHAMIDE (45)
TADALAFIL (41)
BOSENTAN (39)
BUSULFAN (33)
Which MITOMYCIN Alternatives Have Lower Pulmonary veno-occlusive disease Risk?
MITOMYCIN vs MITOTANE
MITOMYCIN vs MITOXANTRONE
MITOMYCIN vs MITRAGYNINE\HERBALS
MITOMYCIN vs MIZORIBINE
MITOMYCIN vs MOBOCERTINIB